首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

1356767

大腸直腸癌市場報告：2030 年趨勢、預測與競爭分析

Colorectal Cancer Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: 2023年09月01日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

大腸直腸癌趨勢和預測

預計到 2030 年，全球大腸癌市場將達到 219 億美元，2024 年至 2030 年年複合成長率為 4.1%。這個市場的主要促進因素是老年人口的增加、不健康的飲食習慣和異食癖時間的增加以及人們對結直腸癌的認知不斷增強。全球大腸直腸癌市場前景未來性，有手術/放射線治療、化療、標靶治療、抗藥性治療等市場機會。

大腸直腸癌市場洞察

Lucintel 預測，由於人們越來越關注各種具有準確診斷測試的治療程序，直腸指檢將在預測期內實現最高成長。

化療是大腸直腸癌最常見的治療方法，因為它通常涉及靜脈或口服給藥抗癌藥物，這些藥物透過血流直接輸送到體內。

由於消費者對大腸直腸癌診斷和治療的認知不斷提高，以及政府對該地區結直腸癌治療和藥物開發的支持力度加大，預計北美地區在預測期內將經歷最高的成長。

本報告回答了 11 個關鍵問題：

Q.1. 細分市場中最有前途和高成長的機會是什麼？
Q.2.哪個細分市場將以更快的速度成長？為什麼？
Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
Q.4. 影響市場動態的主要要素有哪些？市場的主要挑戰和商業風險是什麼？
Q.5. 這個市場的商業風險和競爭威脅是什麼？
Q.6.這個市場有哪些新趨勢？為什麼？
Q.7.市場客戶需求有何改變？
Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
Q.10. 該市場上的競爭產品有哪些，由於材料或產品替代導致市場佔有率下降的威脅有多大？
Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

宏觀經濟趨勢（2018-2023）與預測（2024-2030）
全球大腸直腸癌市場趨勢（2018-2023）與預測（2024-2030）
全球大腸直腸癌診斷市場
- 手指直腸檢查
- 大便潛血試驗
- 軟式乙狀結腸鏡檢查
- 內視鏡
- 虛擬內視鏡
全球大腸直腸癌治療市場
- 手術/放射線治療
- 化療
- 標靶治療
- 對藥物治療產生抗藥性
- 其他

第4章 2018-2030年分地區市場趨勢及預測分析

按地區分類的全球大腸直腸癌市場
北美大腸癌市場
歐洲大腸直腸癌市場
亞太大腸直腸癌市場
其他地區大腸直腸癌市場

第5章競爭分析

產品系列分析
營運整合
波特五力分析

第6章成長機會與策略分析

成長機會分析
- 全球大腸直腸癌市場診斷成長機會
- 全球大腸直腸癌治療市場成長機會
- 按地區分類的全球大腸直腸癌市場成長機會
全球大腸直腸癌市場新趨勢
戰略分析
- 新產品開發
- 擴大全球大腸直腸癌市場的產能
- 全球大腸直腸癌市場的合併、收購與合資企業
- 認證和許可

第7章主要企業概況

Abbott Diagnostics
Alere
Beckman Coulter
Clinical Genomics
Companion Dx
Hoffmann La Roche
Debiopharm
Vaccinogen BD

簡介目錄

Colorectal Cancer Trends and Forecast

The future of the global colorectal cancer market looks promising with opportunities in the urgery & radiation therapy, chemotherapy, targeted therapies, and resistance to pharmacological therapies markets. The global colorectal cancer market is expected to reach an estimated $21.9 billion by 2030 with a CAGR of 4.1% from 2024 to 2030. The major drivers for this market are growing geriatric population, increasing unhealthy food habits and odd food consumption timing of individual, and rising awareness towards colorectal cancer.

A more than 150-page report is developed to help in your business decisions.

Colorectal Cancer by Segment

The study includes a forecast for the global colorectal cancer by diagnosis, treatment, and region.

Colorectal Cancer Market by Diagnosis [Shipment Analysis by Value from 2018 to 2030]:

Digital Rectal Examination
Fecal Occult Blood Test
Flexible Sigmoidoscopy
Colonoscopy
Virtual Colonoscopy

Colorectal Cancer Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

Surgery and Radiation Therapy
Chemotherapy
Targeted Therapies
Resistance to Pharmacological Therapies
Others

Colorectal Cancer Market by Region [Shipment Analysis by Value from 2018 to 2030]:

North America
Europe
Asia Pacific
The Rest of the World

List of Colorectal Cancer Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies colorectal cancer companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the colorectal cancer companies profiled in this report include-

Abbott Diagnostics
Alere
Beckman Coulter
Clinical Genomics
Companion Dx
Hoffmann La Roche
Debiopharm
Vaccinogen BD

Colorectal Cancer Market Insights

Lucintel forecasts that digital rectal examination is expected to witness highest growth over the forecast period due to growing prominence for the various treatment procedures by performing accurate diagnostic tests.

Within this market, chemotherapy will remain the largest segment as it is generally a treatment with injectable cancer drugs into a vein or orally by mouth, which helps them directly reach body parts through the bloodstream travel and is the most commonly used method to treat colorectal cancer.

North America is expected to witness highest growth over the forecast period due to the increasing awareness among consumers about the diagnosis and treatment of colorectal cancer and growing government support to develop colorectal cancer procedures and drugs in this region.

Features of the Global Colorectal Cancer Market

Market Size Estimates: Colorectal cancer market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Colorectal cancer market size by diagnosis, treatment, and region. in terms of value ($B).

Regional Analysis: Colorectal cancer market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different diagnosis, treatment, and region.s for the colorectal cancer market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the colorectal cancer market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the colorectal cancer market size?

Answer: The global colorectal cancer market is expected to reach an estimated $21.9 billion by 2030.

Q.2. What is the growth forecast for colorectal cancer market?

Answer: The global colorectal cancer market is expected to grow with a CAGR of 4.1% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the colorectal cancer market?

Answer: The major drivers for this market are growing geriatric population, increasing unhealthy food habits and odd food consumption timing of individual, and rising awareness towards colorectal cancer.

Q.4. What are the major segments for colorectal cancer market?

Answer: The future of the colorectal cancer market looks promising with opportunities in the urgery & radiation therapy, chemotherapy, targeted therapies, and resistance to pharmacological therapies markets.

Q.5. Who are the key colorectal cancer market companies?

Answer: Some of the key colorectal cancer companies are as follows:

Abbott Diagnostics
Alere
Beckman Coulter
Clinical Genomics
Companion Dx
Hoffmann La Roche
Debiopharm
Vaccinogen BD

Q.6. Which colorectal cancer market segment will be the largest in future?

Answer: Lucintel forecasts that digital rectal examination is expected to witness highest growth over the forecast period due to growing prominence for the various treatment procedures by performing accurate diagnostic tests.

Q.7. In colorectal cancer market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to the increasing awareness among consumers about the diagnosis and treatment of colorectal cancer and growing government support to develop colorectal cancer procedures and drugs in this region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the colorectal cancer market by diagnosis (digital rectal examination, fecal occult blood test, flexible sigmoidoscopy, colonoscopy, and virtual colonoscopy), treatment (surgery & radiation therapy, chemotherapy, targeted therapies, resistance to pharmacological therapies, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Global Colorectal Cancer Market : Market Dynamics

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Colorectal Cancer Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Colorectal Cancer Market by Diagnosis
- 3.3.1: Digital Rectal Examination
- 3.3.2: Fecal Occult Blood Test
- 3.3.3: Flexible Sigmoidoscopy
- 3.3.4: Colonoscopy
- 3.3.5: Virtual Colonoscopy
3.4: Global Colorectal Cancer Market by Treatment
- 3.4.1: Surgery and Radiation Therapy
- 3.4.2: Chemotherapy
- 3.4.3: Targeted Therapies
- 3.4.4: Resistance to Pharmacological Therapies
- 3.4.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

4.1: Global Colorectal Cancer Market by Region
4.2: North American Colorectal Cancer Market
- 4.2.2: North American Colorectal Cancer Market by Treatment: Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies, and Others
4.3: European Colorectal Cancer Market
- 4.3.1: European Colorectal Cancer Market by Diagnosis: Digital Rectal Examination, Fecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, and Virtual Colonoscopy
- 4.3.2: European Colorectal Cancer Market by Treatment: Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies, and Others
4.4: APAC Colorectal Cancer Market
- 4.4.1: APAC Colorectal Cancer Market by Diagnosis: Digital Rectal Examination, Fecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, and Virtual Colonoscopy
- 4.4.2: APAC Colorectal Cancer Market by Treatment: Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies, and Others
4.5: ROW Colorectal Cancer Market
- 4.5.1: ROW Colorectal Cancer Market by Diagnosis: Digital Rectal Examination, Fecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, and Virtual Colonoscopy
- 4.5.2: ROW Colorectal Cancer Market by Treatment: Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies, and Others

5. Competitor Analysis

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Colorectal Cancer Market by Diagnosis
- 6.1.2: Growth Opportunities for the Global Colorectal Cancer Market by Treatment
- 6.1.3: Growth Opportunities for the Global Colorectal Cancer Market by Region
6.2: Emerging Trends in the Global Colorectal Cancer Market
6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Colorectal Cancer Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Colorectal Cancer Market
- 6.3.4: Certification and Licensing